Skip to content

NeoGenomics NEO Gross Profit

Gross Profit at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$1.01B+6.9%
Personalis, Inc. logo
Personalis, Inc.PSNL
$281K-96.1%
GeneDx Holdings logo
GeneDx HoldingsWGS
$68.21M+16.6%
Opko Health logo
Opko HealthOPK
$45.76M+7.4%
Quest Diagnostics logo
Quest DiagnosticsDGX
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B-21.0%
Enterprise value$1.6B-5.6%
P/S2.3×-0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Calculated from NeoGenomics’s reported figures.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's gross profit?
NeoGenomics (NEO) reported gross profit of $80.86M in Q1 2026.
How has NeoGenomics's gross profit changed year-over-year?
NeoGenomics's gross profit increased by 10.4% year-over-year, from $73.25M to $80.86M.
What is the long-term trend for NeoGenomics's gross profit?
Over 4 years (2021 to 2025), NeoGenomics's gross profit has grown at a 13.9% compound annual growth rate (CAGR), from $187.06M to $314.29M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.